Stephen Fitzsimons1, Silvia Oggero2, Robyn Bruen1, Cathal McCarthy3, Moritz J Strowitzki4, Niall G Mahon4,5, Nicola Ryan5, Eoin P Brennan1, Mary Barry6, Mauro Perretti2, Orina Belton1. 1. Diabetes Complications Research Centre, School of Biomolecular and Biomedical Science, Conway Institute, University College Dublin, Dublin, Ireland. 2. William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, United Kingdom. 3. Department of Pharmacology and Therapeutics, University College Cork, Cork, Ireland. 4. School of Medicine and Medical Science, University College Dublin, Dublin, Ireland. 5. Department of Cardiology, Mater Misericordiae University Hospital, Dublin, Ireland. 6. Department of Vascular Surgery, St. Vincent's University Hospital, Dublin, Ireland.
Abstract
Background: Atherosclerosis is a chronic inflammatory disease driven by macrophage accumulation in medium and large sized arteries. Macrophage polarization and inflammation are governed by microRNAs (miR) that regulate the expression of inflammatory proteins and cholesterol trafficking. Previous transcriptomic analysis led us to hypothesize that miR-155-5p (miR-155) is regulated by conjugated linoleic acid (CLA), a pro-resolving mediator which induces regression of atherosclerosis in vivo. In parallel, as extracellular vesicles (EVs) and their miR content have potential as biomarkers, we investigated alterations in urinary-derived EVs (uEVs) during the progression of human coronary artery disease (CAD). Methods: miR-155 expression was quantified in aortae from ApoE-/- mice fed a 1% cholesterol diet supplemented with CLA blend (80:20, cis-9,trans-11:trans-10,cis-12 respectively) which had been previously been shown to induce atherosclerosis regression. In parallel, human polarized THP-1 macrophages were used to investigate the effects of CLA blend on miR-155 expression. A miR-155 mimic was used to investigate its inflammatory effects on macrophages and on ex vivo human carotid endarterectomy (CEA) plaque specimens (n = 5). Surface marker expression and miR content were analyzed in urinary extracellular vesicles (uEVs) obtained from patients diagnosed with unstable (n = 12) and stable (n = 12) CAD. Results: Here, we report that the 1% cholesterol diet increased miR-155 expression while CLA blend supplementation decreased miR-155 expression in the aorta during atherosclerosis regression in vivo. CLA blend also decreased miR-155 expression in vitro in human THP-1 polarized macrophages. Furthermore, in THP-1 macrophages, miR-155 mimic decreased the anti-inflammatory signaling proteins, BCL-6 and phosphorylated-STAT-3. In addition, miR-155 mimic downregulated BCL-6 in CEA plaque specimens. uEVs from patients with unstable CAD had increased expression of miR-155 in comparison to patients with stable CAD. While the overall concentration of uEVs was decreased in patients with unstable CAD, levels of CD45+ uEVs were increased. Additionally, patients with unstable CAD had increased CD11b+ uEVs and decreased CD16+ uEVs. Conclusion: miR-155 suppresses anti-inflammatory signaling in macrophages, is decreased during regression of atherosclerosis in vivo and is increased in uEVs from patients with unstable CAD suggesting miR-155 has potential as a prognostic indicator and a therapeutic target.
Background: Atherosclerosis is a chronic inflammatory disease driven by macrophage accumulation in medium and large sized arteries. Macrophage polarization and inflammation are governed by microRNAs (miR) that regulate the expression of inflammatory proteins and cholesterol trafficking. Previous transcriptomic analysis led us to hypothesize that miR-155-5p (miR-155) is regulated by conjugated linoleic acid (CLA), a pro-resolving mediator which induces regression of atherosclerosis in vivo. In parallel, as extracellular vesicles (EVs) and their miR content have potential as biomarkers, we investigated alterations in urinary-derived EVs (uEVs) during the progression of humancoronary artery disease (CAD). Methods:miR-155 expression was quantified in aortae from ApoE-/- mice fed a 1% cholesterol diet supplemented with CLA blend (80:20, cis-9,trans-11:trans-10,cis-12 respectively) which had been previously been shown to induce atherosclerosis regression. In parallel, human polarized THP-1 macrophages were used to investigate the effects of CLA blend on miR-155 expression. A miR-155 mimic was used to investigate its inflammatory effects on macrophages and on ex vivo human carotid endarterectomy (CEA) plaque specimens (n = 5). Surface marker expression and miR content were analyzed in urinary extracellular vesicles (uEVs) obtained from patients diagnosed with unstable (n = 12) and stable (n = 12) CAD. Results: Here, we report that the 1% cholesterol diet increased miR-155 expression while CLA blend supplementation decreased miR-155 expression in the aorta during atherosclerosis regression in vivo. CLA blend also decreased miR-155 expression in vitro in humanTHP-1 polarized macrophages. Furthermore, in THP-1 macrophages, miR-155 mimic decreased the anti-inflammatory signaling proteins, BCL-6 and phosphorylated-STAT-3. In addition, miR-155 mimic downregulated BCL-6 in CEA plaque specimens. uEVs from patients with unstable CAD had increased expression of miR-155 in comparison to patients with stable CAD. While the overall concentration of uEVs was decreased in patients with unstable CAD, levels of CD45+ uEVs were increased. Additionally, patients with unstable CAD had increased CD11b+ uEVs and decreased CD16+ uEVs. Conclusion:miR-155 suppresses anti-inflammatory signaling in macrophages, is decreased during regression of atherosclerosis in vivo and is increased in uEVs from patients with unstable CAD suggesting miR-155 has potential as a prognostic indicator and a therapeutic target.
Authors: Lidia Daimiel-Ruiz; Mercedes Klett-Mingo; Valentini Konstantinidou; Victor Micó; Juan Francisco Aranda; Belén García; Javier Martínez-Botas; Alberto Dávalos; Carlos Fernández-Hernando; José Maria Ordovás Journal: Mol Nutr Food Res Date: 2015-09 Impact factor: 5.914
Authors: Viviana Cobos Jiménez; Edward J Bradley; Antonius M Willemsen; Antoine H C van Kampen; Frank Baas; Neeltje A Kootstra Journal: Physiol Genomics Date: 2013-12-10 Impact factor: 3.107
Authors: Adrian Santelli; In O Sun; Alfonso Eirin; Abdelrhman M Abumoawad; John R Woollard; Amir Lerman; Stephen C Textor; Amrutesh S Puranik; Lilach O Lerman Journal: J Am Heart Assoc Date: 2019-06-01 Impact factor: 5.501
Authors: Javier Perez-Hernandez; Dolores Olivares; Maria J Forner; Ana Ortega; Elena Solaz; Fernando Martinez; Felipe J Chaves; Josep Redon; Raquel Cortes Journal: J Transl Med Date: 2018-08-14 Impact factor: 5.531
Authors: Doaa I Mohamed; Dalia Alaa El-Din Aly El-Waseef; Enas S Nabih; Omnyah A El-Kharashi; Hanaa F Abd El-Kareem; Hebatallah H Abo Nahas; Basel A Abdel-Wahab; Yosra A Helmy; Samar Zuhair Alshawwa; Essa M Saied Journal: Pharmaceutics Date: 2022-02-27 Impact factor: 6.321